Business ❯ Healthcare

Corporate Governance

Leadership Executive Leadership Leadership Changes Executives Executive Security Board of Directors Insurance Industry CEO Accountability Impact of Crime on Business Healthcare Industry Crisis Management Executive Compensation Industry Trends Violence Prevention Stock Performance CEO Executive Participation Financial Reporting Legal Issues Bankruptcy Management Investor Relations Executive Misconduct Employee Safety

BioRestorative Prices $1.085 Million Direct Offering at $1.60 With Concurrent Warrants

The financing is intended to extend near-term runway for the company’s development programs.

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us

Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.